![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
KP Anderson, JA Lloyd, E Ponce, SC Crable, JC Neumann and JB Lingrel
Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, Ohio 45267-0524.
Transgenic mice have been used extensively to study elements governing the erythroid-specific developmental switch from human fetal gamma to human adult beta globin. Previous work demonstrated that a small construct composed of hypersensitive site 2 (HS2) of the locus control region (LCR) linked to the gamma and beta globin genes (HS2-gamma-beta) is sufficient for correct tissue and temporal expression of these genes, whereas HS2-beta alone is inappropriately expressed in the embryo. Two models, which are not mutually exclusive, have been proposed to explain these results and those of other constructs in transgenic mice. One model emphasizes the conserved polarity in the globin locus and suggests a distance effect whereby the beta globin gene must be removed from the LCR/HS2 to prevent an early and incorrect activation of this gene in the embryonic compartment. A second hypothesis proposes a competition between the gamma and beta globin gene promoters for interaction with the LCR/HS2. The active gamma globin gene promoter positioned between the LCR/HS2 and the beta globin gene thereby interacts with the HS2 elements early in erythroid development and is expressed until a change in putative stage-specific nuclear factors makes an interaction with the adult beta globin gene more favorable. In an effort to test the competition model, a construct has been prepared in which a small deletion was produced in the promoter region of the gamma globin gene while in the context of the HS2-gamma-beta plasmid. Analysis of this construct in transgenic mice reveals a constitutive unregulated expression of the human beta globin gene during erythroid development.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  T. G. Sargent and J. A. Lloyd The Human gamma -Globin TATA and CACCC Elements Have Key, Distinct Roles in Suppressing beta -Globin Gene Expression in Embryonic/Fetal Development J. Biol. Chem., November 2, 2001; 276(45): 41817 - 41824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhou, D. R. Clouston, X. Wang, L. Cerruti, J. M. Cunningham, and S. M. Jane Induction of Human Fetal Globin Gene Expression by a Novel Erythroid Factor, NF-E4 Mol. Cell. Biol., October 15, 2000; 20(20): 7662 - 7672. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. M. Ryan, C.-W. Sun, J. Ren, and T. M. Townes Human {gamma}-globin gene promoter element regulates human {beta}-globin gene developmental specificity Nucleic Acids Res., July 15, 2000; 28(14): 2736 - 2740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Sargent, C. C. DuBois, A. M. Buller, and J. A. Lloyd The Roles of 5'-HS2, 5'-HS3, and the gamma -Globin TATA, CACCC, and Stage Selector Elements in Suppression of beta -Globin Expression in Early Development J. Biol. Chem., April 16, 1999; 274(16): 11229 - 11236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Sabatino, A. P. Cline, P. G. Gallagher, L. J. Garrett, G. Stamatoyannopoulos, B. G. Forget, and D. M. Bodine Substitution of the Human beta -Spectrin Promoter for the Human Agamma -Globin Promoter Prevents Silencing of a Linked Human beta -Globin Gene in Transgenic Mice Mol. Cell. Biol., November 1, 1998; 18(11): 6634 - 6640. [Abstract] [Full Text]
|
|
|
|
|
|
A. W. Bell, J.-G. Jiang, Q. Chen, Y. Liu, and R. Zarnegar The Upstream Regulatory Regions of the Hepatocyte Growth Factor Gene Promoter Are Essential for Its Expression in Transgenic Mice J. Biol. Chem., March 20, 1998; 273(12): 6900 - 6908. [Abstract] [Full Text] [PDF]
|
|
